Thermo Fisher Scientific Inc. (TMO)
- Previous Close
571.25 - Open
579.84 - Bid 540.00 x 800
- Ask 580.00 x 800
- Day's Range
571.63 - 579.84 - 52 Week Range
415.60 - 603.82 - Volume
1,749,670 - Avg. Volume
1,339,563 - Market Cap (intraday)
218.487B - Beta (5Y Monthly) 0.80
- PE Ratio (TTM)
36.76 - EPS (TTM)
15.57 - Earnings Date Jul 24, 2024 - Jul 29, 2024
- Forward Dividend & Yield 1.56 (0.27%)
- Ex-Dividend Date Mar 14, 2024
- 1y Target Est
622.29
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
www.thermofisher.com122,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: TMO
Performance Overview: TMO
Trailing total returns as of 5/3/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TMO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TMO
Valuation Measures
Market Cap
218.49B
Enterprise Value
246.84B
Trailing P/E
36.71
Forward P/E
26.53
PEG Ratio (5yr expected)
2.31
Price/Sales (ttm)
5.21
Price/Book (mrq)
4.80
Enterprise Value/Revenue
5.81
Enterprise Value/EBITDA
21.76
Financial Highlights
Profitability and Income Statement
Profit Margin
14.20%
Return on Assets (ttm)
4.82%
Return on Equity (ttm)
13.62%
Revenue (ttm)
42.49B
Net Income Avi to Common (ttm)
6.03B
Diluted EPS (ttm)
15.57
Balance Sheet and Cash Flow
Total Cash (mrq)
7.25B
Total Debt/Equity (mrq)
78.05%
Levered Free Cash Flow (ttm)
6.08B
Research Analysis: TMO
Company Insights: TMO
TMO does not have Company Insights